Underuse of oral anticoagulants in privately insured patients with atrial fibrillation: A population being targeted by the IMplementation of a randomized controlled trial to imProve treatment with oral AntiCoagulanTs in patients with Atrial Fibrillation (IMPACT-AFib)

Published in American Heart Journal, November 1, 2020 | Online publication on June 24, 2020

Author(s): Sana M Al-Khatib, Sean D Pokorney, Hussein R Al-Khalidi, Kevin Haynes, Crystal Garcia, David Martin, Jennifer C Goldsack, Thomas Harkins, Noelle M Cocoros, Nancy D Lin, Hana Lipowicz, Debbe McCall, Vinit Nair, Lauren E Parlett, Cheryl McMahill-Walraven, Richard Platt, Christopher B Granger

DOI: 10.1016/j.ahj.2020.07.012 | Pubmed ID: 32949986

Abstract

Tags

Analytic: No tags set.

Data Source: No tags set.

Research Focus: No tags set.

Study Design: No tags set.

Funding Transparency

No funding has been identified for this publication.

Entry last updated (DMY): 28-11-2024.

Disclaimer

The content of this website, including articles, papers, and any other materials, reflects my personal views and opinions. They do not necessarily represent the views or opinions of my employer, colleagues, or any affiliated organizations. Unless explicitly stated otherwise, this content was generated without the use of any generative AI or large language models (LLMs); all information presented here is solely the result of human input and research.

I may provide links to external websites for convenience or reference, but this does not constitute an endorsement of those sites or the content within them. I am not responsible for the content, accuracy, or reliability of any external websites.

All information shared on this website is for informational purposes only and should not be construed as professional advice.

2024 Lauren Elizabeth Parlett, PhD - Epidemiologist. All rights reserved.

site admin | credits